ReviewTherapeutics and clinical risk management2014

Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.

Yi-Ting Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.